Related by context. All words. (Click for frequent words.) 57 Mr. Rosconi 56 Mr. Pierre Laurin 55 faropenem 55 OvaRex R 55 MAXY VII 54 Technosphere Insulin 54 FLUVIRIN vaccine 54 Hedgehog antagonist 53 Mr. Movens 53 Mr. Jassawalla 53 FACTIVE tablets 53 Daniel Junius 53 MAXY alpha 53 BLA filing 53 Dr. Marlies Sproll 53 GALNS 53 Dr. Stylli 53 TOCOSOL Paclitaxel 53 Dr. Aiping Young 52 BIM #A# 52 Cytolin ® 52 ESTRASORB 52 Medidur FA 52 Mr. Yves Rosconi 52 Antony Koblish President 52 SILENOR 52 Steven B. Ratoff 52 DRAXIS 52 UVIDEM 52 Altastaph 51 Mr. Jinsheng Ren 51 Stimuvax R 51 Shai N. Gozani 51 PhosLo 51 Kirsten Drejer 51 Phase lll 51 PRESEPT study 51 Flutiform TM 51 Nabi HB 51 transcatheter valve technologies 51 novel trazodone formulation 51 Daniel H. Movens 51 rindopepimut 51 Mr. Kriegsman 51 Mark A. Sirgo 51 WILEX 51 Alton Boynton 51 TBC# 51 CMV vaccine 51 Pedro Lichtinger 51 MPL adjuvant 51 John Maraganore Ph.D. 51 pradefovir 51 Dr. Fahar Merchant 51 THALOMID 51 Allovectin 7 51 Dr. Yatscoff 51 Civacir 51 Panzem R NCD 51 Urocidin 51 Dr. Grodman 51 AEterna 51 pexiganan 50 R#/MEM # 50 Gord Froehlich President 50 rThrombin 50 PEG SN# 50 QTinno TM 50 oral taxane 50 Syntonix 50 Theratope 50 IV APAP 50 Marc Oczachowski 50 Fibrillex TM 50 Mr. Feldenkreis 50 Mr. Meshgin 50 Dr. Tsengas 50 Mr. Melnuk 50 Ms. Bronicki 50 Barry D. Quart 50 ThromboGenics commented 50 PDE# inhibitors 50 Protalex 50 Georges Gemayel 50 Juergen Engel Ph.D. 50 Onno van de Stolpe 50 successfully commercialize Iluvien 50 Thorough QT 50 GLP toxicology studies 50 TransVax tm 50 Jal S. Jassawalla 50 Howard H. Pien 49 Voraxaze ™ 49 Murray Tekmira 49 Lonnie Moulder 49 MyVax ® 49 Surfaxin LS 49 Virulizin ® 49 Chimigen TM 49 Len Perham MoSys 49 Bioproducts segment 49 Dr. Damaj 49 Etubics 49 Ramoplanin 49 MAA submission 49 Harry Palmin President 49 Fran DiNuzzo 49 Mr. Bentsur 49 Mr. Luc Mainville 49 AGGRASTAT ® 49 Phenoptin 49 CRD5 49 stated Xiaofeng Peng 49 IND submission 49 Dr. Arndt Schottelius 49 MCOT TM 49 Dr. Raafat Fahim 49 Bionutrics 49 Dr. Wayne Danter 49 Nicole Onetto MD 49 Ms. Katen 49 Mr. Bassoul 49 forodesine 49 Relypsa 49 Donald L. Drakeman 49 Mr. Klusas 49 alvespimycin 49 Camvia 49 Alzhemed TM 49 DSMB recommendation 49 Anthony DiTonno President 49 Zavesca r 49 OHR/AVR# 49 Mr. Weidong Yin 49 Gujiao facility 49 Naturlose 49 CytoFabTM 49 leveraging ATG 49 ThromboGenics 49 midstage trials 49 DPX Survivac 48 Solasia 48 Ronan O'Caoimh CEO 48 Dr. Zandman 48 EGRIFTA ™ 48 SPARLON 48 Jinan Fertilizer 48 AFFITOME R 48 Philippe Archinard 48 Ron Bentsur 48 OvaRex 48 Elisabeth Lindner CEO 48 Mr. Williger 48 oral picoplatin 48 Christian Itin 48 Dr. Sirgo 48 Don Kiepert President 48 Relivar 48 epigenetic therapies 48 nalbuphine ER 48 Tony Milici 48 TRISENOX 48 Manja Bouman CEO 48 RIGScan CR 48 PGxPredict tests 48 initiate Phase 1b 48 NicOx commented 48 incyclinide 48 Adrian Hobden Ph.D. 48 Phase #b/#a 48 NUVIGIL 48 Cytolin R 48 Insegia 48 Troxatyl 48 Patrik De Haes 48 faropenem medoxomil 48 Per Olof Wallström 48 StemEx R 48 Dextofisopam 48 Æterna Zentaris 48 Evoltra ® 48 TKM ApoB 48 Stephen Ghiglieri 48 Targretin capsules 48 SonoLysis 48 Dr. Rahul Singhvi 48 Jifan Gao 48 Mr. Armando Anido 48 ApoB SNALP 48 L BLP# 48 Daniel Passeri Curis 48 MediGene focuses 48 BIOCEUTICALS 48 Gilles Gagnon 48 bicifadine 48 Prolor 48 Zingo TM 48 Tovaxin TM 48 Erlen 48 Chemophase 48 eTag assays 48 Rosen ViroPharma 48 atacicept 48 celgosivir 48 Neil K. Warma 47 Viramidine 47 Lisa N. Drakeman 47 IoGen 47 DCVax R 47 GENASIS trial 47 Bernd R. Seizinger 47 Lixivaptan 47 EGRIFTA TM 47 Peter Riehl Stellar 47 Geoffrey Rotstein 47 Mr. Hasselbusch 47 MAGE A3 ASCI 47 Mr. Sondey 47 Dominique Costantini 47 pegloticase 47 Mr. Fater 47 Dr. Horst Zerbe 47 LibiGel BioSante 47 Ofer Haviv Evogene 47 preclinically 47 Dr. Sosne 47 von Rickenbach 47 Xiaofeng Peng Chairman 47 Dr. Shrotriya 47 Michael H. Tardugno 47 maribavir 47 Mr. Owusu Akyaw 47 Bioral Amphotericin B 47 anticoagulant reversing agent 47 Malcolm Skolnick CytoGenix 47 Philippe Calais 47 histrelin manufacturing marketing 47 Study #CL# 47 ImmuneY2 47 Heplisav 47 APTIMA HPV assay 47 vidofludimus 47 NanoKnife IRE System 47 Faheem Hasnain 47 tezampanel 47 Phase IIb trials 47 Cytolin 47 TOLAMBA 47 IIa trial 47 PNT# 47 ourproducts 47 INCB# [001] 47 trastuzumab DM1 T DM1 47 UPLYSO 47 Kiadis Pharma 47 INTEGRILIN R eptifibatide Injection 47 ularitide 47 HepeX B 47 PSMA ADC 47 Jinpan commented 47 Can Fite 47 HCV protease inhibitors 47 Cinryze ™ 47 Attrius ® 47 outlicensing 47 cannabinor 47 Neuradiab 47 Rik J Deitsch 47 inecalcitol 47 Sernova 47 Ph.D. Targacept 47 Memryte 47 Kleanthis G. Xanthopoulos Ph.D. 47 Martin Nicklasson CEO 47 Emezine 47 URG# 47 InteKrin 47 Dyax phage display 47 oral PTH 47 Renaud Beauchesne 47 Jeffrey H. Buchalter 47 BB BIOTECH 47 Candace Kendle PharmD 46 CCR5 receptor antagonist 46 Doliveux 46 Dr. LaMattina 46 Spiegelmer ® 46 Solos Endoscopy 46 LibiGel Phase III 46 Opexa 46 deforolimus 46 TOPIGEN 46 sirtuin modulators 46 Lung Rx 46 liprotamase 46 OMAPRO 46 Adventrx 46 Attain IVF Program 46 initiate Phase 2b 46 Loretta M. Itri 46 MGI PHARMA marketed 46 EndoTAG TM 46 Dr. Scangos 46 Ruiz Comas 46 Dino Dina 46 inhaled AAT 46 ostarine 46 EP #R 46 Ulrich Dauer CEO 46 SNT MC# 46 Luc Tanguay 46 JM Dutton adds 46 RLY# 46 Simon Sturge 46 Addrenex 46 LibiGel ® testosterone gel 46 Aegera 46 Anthony Giovinazzo 46 Canvaxin 46 Roch Doliveux CEO 46 subsidiaries visit http:/www.apricusbio.com 46 NEBIDO 46 Dr. Ayalew Tefferi 46 MIGENIX 46 Andrin Oswald CEO 46 CR# vcMMAE 46 Medicare Advantage MLR 46 immatics 46 oral ridaforolimus 46 Trofex 46 PANVAC VF 46 Werner Cautreels 46 EnzymeRx 46 Santhera 46 Loramyc TM 46 ERYtech Pharma 46 Mihael Polymeropoulos MD 46 GRN# 46 HuMax CD4 46 Restanza 46 Mr. Carmilani 46 AERx iDMS 46 BrachySil TM 46 glucokinase activator 46 Christopher Anzalone Arrowhead 46 isavuconazole 46 Neogenix 46 MorphoSys proprietary 46 Inc. NASDAQ ICGN 46 Frank Baldino Jr. 46 CCR9 antagonist 46 BioFX 46 BioNumerik 46 stated Per Loof 46 adrenergic regulation 46 Dr. Seizinger 46 aplindore 46 4SC commented 46 alvimopan 46 Egrifta 46 Dr. Gozani 46 Inflazyme 46 Anavex #-# 46 Butchofsky 46 omacetaxine 46 Bicifadine 46 RSD# 45 Tod Woolf Ph.D. 45 PROMACTA 45 torsemide ER 45 Velac 45 therapeutic monoclonal antibodies 45 Peer Schatz 45 balsalazide tablet 45 CKD ND 45 generic Flomax 45 Becancour facilities 45 Panzem 45 ESBATech 45 Domilens 45 therapy PBRT 45 Phase III LibiGel 45 Safi Bahcall Ph.D. 45 Mr. Contesse 45 Proellex TM 45 ageLOC Vitality 45 vosaroxin 45 Repros 45 confirmatory Phase 3 45 Clay B. Siegall 45 Nanobiotix 45 Removab 45 Thalomid ® 45 oral methylnaltrexone 45 Dr. Randall Yatscoff 45 OGeS 45 Haim Aviv 45 zanolimumab 45 OvaRex ® MAb 45 Corautus 45 AEterna Zentaris 45 AVAX 45 cMET 45 lumiliximab 45 XP #L 45 David Aviezer 45 Mr. Shokrgozar 45 GEHC 45 Stragen 45 Mr. Mordock 45 VSEL technology 45 HuLuc# 45 pafuramidine 45 Ms. Dressel 45 BioGeneriX 45 Tambakeras 45 PROCHYMAL 45 otelixizumab 45 Pimavanserin 45 Isis antisense 45 KIACTA ™ 45 budesonide foam 45 collaborator Genentech 45 ICA # 45 Loïc Maurel MD 45 EnVivo 45 VIRxSYS 45 Sopherion 45 Ms. Lurker 45 Brian JG Pereira 45 JAK inhibitors 45 Mr. Longever 45 Dr. Isa Odidi 45 refractory CLL 45 Megace R ES 45 Veronate 45 Dr. Goldknopf 45 illumigene C. difficile 45 Mr. Jinglin Shi 45 Freshest Beer Program 45 LEVADEX ™ 45 Michelle Del Guercio 45 zileuton injection 45 RSD# oral 45 Dan Passeri Curis 45 ImmunoVEX HSV2 45 RhuDex 45 Viprinex TM 45 MD Halozyme 45 novel peptides 45 Robert Motzer MD 45 PROSTVAC TM 45 zileuton IV 45 Symadex 45 LibiGel ® 45 Anna Gluskin 45 Steve Worland Ph.D. 45 velafermin 45 rPA vaccine candidate 45 JAK inhibitor 45 Yves Rosconi 45 Drew Fromkin President 45 JP-#/fipamezole 45 PRECISE trial 45 Carl A. Pelzel 45 Omthera 45 talactoferrin 45 Cutanea 45 Nellix technology 45 Virulizin R 45 octreotide implant 45 Steven R. Deitcher 45 Joseph K. Belanoff 45 lookforward 45 Prestara 45 ThGRF 45 ThromboGenics commenting 45 apricitabine 45 Electrochem Commercial Power 45 Archexin 45 Martin Nicklasson 45 dacetuzumab collaboration 45 Gerard E. Puorro 45 Xcytrin R 45 rALLy trial 44 Plicera 44 Fibrocell 44 CAMPATH 44 Quay MD Ph.D. 44 GFT# 44 CA9 SCAN 44 Joshua Boger Ph.D. 44 torezolid phosphate 44 Peter Bruijns President 44 SMT C# 44 GED aPC 44 RAPTIVA R 44 Duromist ™ 44 novel therapeutic antibodies 44 ponatinib 44 OMNARIS HFA 44 XmAb# 44 Zevalin consolidation 44 Revotar 44 registrational trial 44 Jeffrey M. Ostrove 44 ruxolitinib 44 Robert L. Chioini 44 G#DT 44 Spiro Rombotis President 44 Dr. Philip Toleikis 44 IMA# 44 periodically reassessed 44 Dr. Fombonne 44 Zami Aberman Pluristem 44 Mark Pykett 44 Dacogen injection 44 CRLX# 44 obatoclax 44 SinuNase 44 NeuVax 44 J. Donald deBethizy 44 Christopher J. Schaber 44 tezampanel NGX# 44 Bob Stanzione ARRIS 44 NeoPharm anticipates 44 tramiprosate ALZHEMED TM 44 WACKER POLYSILICON 44 Celmed 44 generic Depakote 44 ganetespib 44 Dr. Manuso 44 Rezular 44 Nabriva 44 immuno therapeutic 44 Yves Rosconi President 44 LEAPS TM 44 Dr. Pingpank 44 PRESEPT 44 Dr. Ash Rofail 44 tubulin inhibitor 44 SCOLR Pharma 44 Drakeman 44 Asentar 44 FluoroPharma 44 TransVax TM 44 Reverset 44 H. Willard Flamel 44 apricitabine ATC 44 IoGen ™ 44 Sean Roosen President 44 Bezielle 44 Mr. Xiangzhi Chen 44 BIPV BAPV 44 PDP MLR 44 ocrelizumab 44 stated Dominique Costantini 44 LidoPAIN SP 44 tocontinue 44 Relovair 44 elvucitabine 44 Blum Cytokinetics 44 Dan Passeri 44 Crisa acquisition 44 romazarit 44 Sol J. Barer 44 Mr. Erhartic 44 Vincent Milano ViroPharma 44 ongoing Phase IIIb 44 macitentan 44 Aquinox 44 NP2 Enkephalin 44 MacroChem 44 leading oral taxane 44 James Manuso 44 tramiprosate Alzhemed TM 44 Severe hypersensitivity reactions 44 Jacob Inbar 44 Alfacell 44 CURE AF 44 Phase Ib study 44 intercarrier compensation payments 44 Dick Alario Chairman 44 Loramyc ® 44 Chang Ahn Rexahn 44 Cascade LifeSciences 44 Steve Bechman 44 QLT# 44 prescription dermatological 44 EVIZON 44 clinical pharmacology studies 44 HDL Selective Delipidation 44 DHHA 44 severe hypercholesterolemia 44 nonclinical studies 44 G. biloba 44 Ketotransdel 44 CDEL commented 44 NetworkFab 44 CDP# 44 Paul Laikind 44 Axentis Pharma 44 Phase IIb clinical trials 44 Androxal ® 44 Dr. Bruno Giannetti 44 Fine Chemicals segment 43 Dr. Bassam Damaj 43 Allovectin 7 ® 43 NEVO ™ 43 stated Bob Segersten 43 Michael V. Novinski 43 stated Jure Sola 43 BRAF V# mutation 43 ProSavin 43 Numoda 43 Polymeropoulos 43 ImmunoCellular Therapeutics 43 Combidex 43 MERLIN TIMI 43 J. Mazzo Ph.D. 43 Cortria 43 CRACM 43 elacytarabine 43 Visian Toric ICL 43 Ampio 43 Mr. Eishen 43 SNS# T 43 Yakatan 43 Estracure 43 Auxilium Pharma 43 BEMA TM Fentanyl 43 Day4 branded 43 BPE Segment 43 heterozygous FH 43 Uvidem 43 HQK 43 Mr. Tardugno 43 Robert L. Bratzler 43 eprodisate Fibrillex TM 43 Therabel 43 Klaus Schollmeier 43 Hematide ™ 43 Cethrin 43 Cethromycin 43 Orosi Mill project 43 spinal nonfusion 43 Cinquil 43 HGS# 43 CobaCyte 43 Anat Cohen Dayag 43 Daniel Vasella Chairman 43 Dr. Henrich Guntermann 43 Glenn A. Oclassen 43 NASDAQ DYAX 43 elotuzumab 43 Aegerion 43 QRxPharma 43 Mr. Schissler 43 Accuro EMR 43 Mr. Schimkaitis 43 RhuDex ® 43 aerosolized surfactant 43 ABSORB trial 43 Michael Fonstein Ph.D. 43 Matthew Emmens 43 Liposomal Grb 2 43 CONBRIZA 43 YONDELIS 43 CINTREDEKIN BESUDOTOX 43 GENR 43 Fereydoun Firouz 43 Enobia 43 tafamidis 43 microelectronic device 43 ONCONASE R 43 Dr. Blobel 43 Stanicky 43 DermaVir Patch 43 lixivaptan 43 oncolytics 43 Dr. Francesco Bellini 43 BENLYSTA ® 43 custirsen 43 Clinuvel 43 Benlysta belimumab 43 CEO Jinjiang Wang 43 NASDAQ IPXL today 43 SinuNase ™ 43 Icatibant 43 RPL# 43 enzastaurin 43 orBec 43 Zerenex 43 p# inhibitor 43 President Walter Merschat 43 DDP# 43 Sijmen de Vries 43 XTLbio 43 Ms. Kitagawa 43 naronapride 43 Bill Forbes Pharm.D 43 bardoxolone 43 Zami Aberman Chairman 43 SNT-MC#/idebenone 43 EKR 43 Phase IIB 43 pivotal bioequivalence 43 durable remissions 43 Errol De Souza 43 André Michel Ballester 43 ANAVEX #-# [001] 43 SurModics Pharmaceuticals 43 favorable pharmacokinetic profile 43 QSGI commented 43 B. Lynne Parshall 43 Diamyd ® 43 Bioaccelerate compounds under 43 Helvea analyst Olav Zilian 43 antibody humanization royalty 43 Neurobionix 43 Karl B. Gemperli 43 genital HPV infections 43 Triapine R 43 Dr. Dirk Buchta 43 biomarker discovery validation 43 t2cure GmbH 43 Gamida Cell 43 NOXXON 43 Remi Barbier 43 eprodisate KIACTA TM 43 GRAVITAS trial 43 registrational 43 USL# 43 John Alshefski Senior 43 seasonally slowest 43 Nuvion 43 Ceflatonin 43 Personalized Immunotherapy 42 phage display technology 42 Elocalcitol 42 Nutralogix 42 Carl Spana Ph.D. 42 Altrazeal R 42 NDA resubmission 42 Nanobody 42 eltrombopag 42 PAION 42 Genz # 42 TEMSO 42 Miravant 42 PXD# 42 injectable interferon 42 generic Copaxone 42 ozarelix 42 tesmilifene 42 Dendreon Provenge 42 blockers angiogenesis inhibitors 42 riociguat 42 Loramyc 42 Anker MD Ph.D. 42 DeveloGen 42 Mr. Godevais 42 oral salmon calcitonin 42 PD2i ® algorithm 42 Rolland Yves Mauvernay 42 CLIRS 42 Theratechnologies 42 E. Olofson 42 KRYSTEXXA TM pegloticase 42 ASSERT trial 42 ALTANA Pharma 42 Arginox 42 Thiovir 42 Alvesco R 42 dalbavancin 42 James Sapirstein 42 eniluracil 42 BEMA Fentanyl 42 EchoCRT 42 Dr. Tashkin 42 GammaCan 42 huC# DM4 42 Astronics AES 42 Vaughn M. Kailian 42 withthis 42 Elisabeth Lindner 42 midstage clinical 42 Traficet EN 42 Biotie 42 Bergenstal 42 Dr. Anil Diwan 42 Diamyd r vaccine 42 vismodegib 42 pharmacokinetic PK study 42 dose escalation phase 42 Urocortin 2 42 Zalbin 42 ATL# [001] 42 EndoTAG TM -1 42 Advitech 42 Bernd Seizinger 42 Telatinib 42 phase IIa clinical 42 Vitaxin 42 Zelnorm Zelmac 42 MTI MTI Micro 42 dexanabinol 42 Mark HN Corrigan 42 BioAlliance 42 Kamada AAT 42 Gregory D. Casciaro 42 tanespimycin 42 budiodarone 42 Guy Nissenson 42 Sam Owusu Akyaw 42 Dr. Maraganore 42 ARIKACE ™ 42 Keryx Biopharmaceuticals 42 trastuzumab DM1 42 Newron 42 SpHb monitoring 42 Keith Katkin 42 Arranon 42 Glenn Saldanha 42 Toraymyxin TM 42 anidulafungin 42 AZILECT ® 42 Phase 2a trial 42 PRIMO CABG 42 NeuroVax 42 aleglitazar 42 Tripep 42 radezolid 42 EpiCeram TM 42 Plenaxis R 42 Iris Loew Friedrich 42 initiate Phase IIb 42 CEO Benhope Munroe 42 INTEGRILIN 42 oral FTY# 42 Martison Project 42 PregLem 42 convenient dosing regimen 42 tramiprosate 42 inhibit metastasis 42 Kevetrin TM 42 Gag polymorphisms 42 Phase IIIb clinical 42 tiapamil 42 Igeneon 42 posi tive 42 maturation inhibitor 42 InteliStaf 42 Hans Joachim Lohrisch 41 Mr. Hidayatallah 41 Oglemilast 41 CINQUIL 41 XcelaSAN ® 41 Biolipox 41 NEUTRAL rating 41 Lu AA# 41 SYGNIS 41 Hedgehog inhibitor 41 Viprinex 41 hoFH 41 CRMD# 41 patriotism Gration 41 dacetuzumab 41 Hönle Group 41 GATTEX TM 41 rhPDGF BB platform 41 HCV antibody 41 phase IIb trial 41 ulimorelin 41 Arpida 41 small molecule PEGylation 41 CAPHOSOL 41 Phase 1b trial 41 Chaim Lebovits President 41 Ken Bero 41 MeiYa 41 IRX 2 41 Frank Verwiel MD 41 LUCENTIS 41 Hedgehog Pathway Inhibitor 41 Anturol TM 41 indibulin 41 ThermoDox ® clinical 41 IMC #B 41 CTAP# Capsules 41 CollaFix ™ 41 Exherin TM 41 Mark Leuchtenberger 41 Stephen M. Simes 41 Hugues de Bantel 41 masitinib 41 Dr. Gussak 41 Ulf Wiinberg 41 digitizing pathology 41 Cohen OPNET 41 DsiRNA 41 bio similars 41 Novosom 41 ENRICH trial 41 Dan O. Dinges 41 ATL/TV# 41 Dr. Cauwenbergh 41 Mr. Siping Fang 41 crutch Spoelstra 41 Friedhelm Blobel Ph.D. 41 ZOLINZA 41 Powerlink stent graft 41 Johan Löf 41 CUSTOM III 41 Enpath ability 41 Phase Ib II 41 ANAVEX 41 Tracleer r 41 EDAP TMS 41 A3 adenosine receptor 41 tosuccessfully 41 KL4 surfactant pipeline 41 Jack Lief Arena 41 Fx #A 41 Honda Asanuma 41 Ms. Bouvette 41 efficacious therapies 41 Joe Gromek Warnaco 41 ELACYT 41 Fauci confessed 41 Dr. Gulfo 41 phase IIa 41 NV1FGF 41 Maraganore 41 Gentium 41 phase IIb 41 gp# vaccine 41 CAELYX 41 darbepoetin alpha 41 RhuDex TM 41 ViroStatics 41 Jean Luc Bélingard Chairman 41 lomitapide 41 Harold Van Wart 41 Alnylam #x# 41 polycrystalline photovoltaic 41 Chief Executive Joergen Vig 41 TACI Ig 41 LibiGel testosterone gel 41 Friedhelm Blobel 41 Vernakalant 41 Timo Veromaa 41 rolapitant 41 stated Frederic Dugre 41 Jean Luc Belingard 41 DELEX 41 WILEX AG 41 capacity utilisations 41 Pascal Pfister 41 VITAL Trial 41 Aviptadil 40 Joseph M. Gingo 40 Richard J. Meelia 40 Mr. Ewigleben 40 ELND# 40 NAbs 40 PHOLED technology 40 farletuzumab 40 brivaracetam 40 Endeavor DES 40 PXI modular instrumentation 40 Shular commented 40 Onrigin 40 fund BioSante LibiGel 40 MEND CABG II 40 eprotirome 40 mifamurtide 40 Phase #b/#a clinical 40 tasimelteon 40 EDEMA3 trial 40 PDE4 inhibitor 40 GGF2 40 Nortel MEN 40 ourability 40 Zeb Horowitz 40 Chris Sapyta 40 Homi Shamir president 40 MedMira rapid 40 David Spaight 40 Francois Nader 40 please visit www.ldksolar.com 40 brownfield expansions 40 Engineered Support Structures Segment 40 potent antiretroviral therapy 40 Dynogen 40 TRO# 40 ARIKACE 40 parthenogenetic stem cell 40 MEK inhibitor RDEA#